Skip to content
Elucidata logo — The AI Partner Fueling
40+ FDA-Track Drugs

Elucidata

The AI Partner Fueling
40+ FDA-Track Drugs

Founded 2015 United States San Francisco, United States 167 employees Series A Total: $23.58M AI, Analytics +5

General Information

Company Name Elucidata
Founded Year 2015
Location United States San Francisco, United States
Employees 167
Industries AI, Analytics, Biotechnology +4
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Service Fee, Tiered Pricing
Offices as of Nov 2026
94114 USCaliforniaSan Francisco, 94114 USCaliforniaSan Francisco 02139 USMassachusettsCambridge, 02139 USMassachusettsCambridge
Social

BounceWatch is an independent company data service, not affiliated with Elucidata. To contact Elucidata, visit elucidata.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Elucidata compare?

A PDF of Elucidata and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Elucidata soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 30, 2026

Elucidata hosted its flagship event #DataFAIRFall2026 featuring a panel on pathology images and biological data.

New Partnership Oct 22, 2026

Elucidata partnered with Axio BioPharma to make scientific data more usable for R&D, process development, and manufacturing.

About Elucidata

Elucidata, founded in 2015, is a pioneering company at the intersection of AI, Machine Learning, and Life Sciences. Headquartered in the United States, Elucidata is transforming the biotech landscape with its innovative data harmonization platform, Polly. Polly is crucial for research and development, allowing scientists to focus on cutting-edge discoveries rather than data management, ultimately accelerating the development of over 40+ FDA-Track Drugs.

Recognized as the 'Most Innovative Biotech Company, 2024' by Fast Company, Elucidata offers a solution to the extensive data wrangling prevalent in early R&D, Precision Diagnostics, and Translational Biomarker research. Polly converts multi-modal biomedical data, such as Omics and Real World Data, into a Unified Data Model, facilitating applications like patient stratification and biomarker discovery. Its client roster includes prestigious names like Pfizer and Janssen Pharmaceuticals.

The company secured a $16M Series A funding in September 2022 from prominent investors including Eight Roads Ventures and F-Prime Capital. With a robust team of 120+ experts across the US and India, Elucidata is well-positioned to continue leading advancements in biotech innovation.

Business keywords: Data Harmonization, Machine Learning Ready Data, Biomedical Data Curation, Multi-Omics Data, Translational Biomarker Discovery, Precision Medicine Diagnostics, Unified Data Model, Drug Discovery, FAIR Data Principles, Life Sciences R&D, Bioinformatics, Therapeutic Asset Identification, Automated Data Curation, Human-in-the-loop Model, Clinical and Commercial Pipelines

Services & Products

Data Harmonization and Integration
AI-Powered Data Processing
Custom Bioinformatics Pipeline Development
Metadata Curation and Management
Clinical and Translational Research Support
Precision Medicine Solutions
Omics Data Analysis

Target Customers

Biopharma Companies Research Institutes Diagnostics Laboratories Biotech Startups Academic Researchers Clinical Research Organizations

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $16.00M 4
Hyperplane, IvyCap Ventures +2
27 Sep 2022
Seed Round $5.00M 3
Hyperplane, IvyCap Ventures +1
28 Jan 2021
Debt Financing $880.00K -
23 Jul 2020
Seed Round $1.70M 1
Hyperplane
18 Jun 2018
Pre Seed Round Undisclosed 1
iBOS Ventures
01 Jan 2017

Elucidata Alternatives & Competitors

View All Alternatives
Elucidata vs
Genialis
Genialis United States

Know your patient, know your drug

Series A
31 employees
Biotechnology, Health Care
Elucidata vs

This page is no longer actively updated. For future updates follow: MindWalk Holdings Corp.

Grant
4 employees
Biotechnology, Life Sciences
Elucidata vs
Multiomic Health
Multiomic Health United Kingdom

AI-Enabled Precision Medicine for Cardiovascular Renal Metabolic (CRM) Disease

Seed
12 employees
AI, Biotechnology

FAQ About Elucidata

The AI Partner Fueling
40+ FDA-Track Drugs
Elucidata was founded in 2015.
Elucidata is headquartered in San Francisco, United States. As of Nov 2026, it also has offices in 94114 USCaliforniaSan Francisco, 94114 USCaliforniaSan Francisco and 02139 USMassachusettsCambridge, 02139 USMassachusettsCambridge.
Elucidata operates in AI, Analytics, Biotechnology, Health Care, Life Sciences, SaaS and Machine Learning. Its work centres on Data Harmonization, Machine Learning Ready Data, Biomedical Data Curation and Multi-Omics Data. Its customers include Biopharma Companies, Research Institutes and Diagnostics Laboratories.
Elucidata has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Service Fee and Tiered Pricing.
Elucidata has approximately 167 employees.
Elucidata has completed 5 funding rounds, raising a total of $23.58M. The latest funding stage is Series A.
Elucidata offers: Data Harmonization and Integration, AI-Powered Data Processing, Custom Bioinformatics Pipeline Development, Metadata Curation and Management, Clinical and Translational Research Support, Precision Medicine Solutions, Omics Data Analysis.
Top alternatives and competitors to Elucidata include Genialis, MindWalk Corp. (formerly BioStrand), Multiomic Health, MNM Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elucidata and Genialis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Elucidata, https://bouncewatch.com/company/elucidata, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout